Plasma exchange in the management of new onset multiple myeloma with cast nephropathy treated with bortezomib based chemotherapy

Affiliations

¹ Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
² Department of Clinical Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
³ Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Comment

J Sethi et al. Nephrology (Carlton). 2017 Dec.

. 2017 Dec;22(12):1035-1036.

doi: 10.1111/nep.12979.

¹ Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
² Department of Clinical Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
³ Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

No abstract available

Comment on

Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains.
Leung N, Gertz MA, Zeldenrust SR, Rajkumar SV, Dispenzieri A, Fervenza FC, Kumar S, Lacy MQ, Lust JA, Greipp PR, Witzig TE, Hayman SR, Russell SJ, Kyle RA, Winters JL. Leung N, et al. Kidney Int. 2008 Jun;73(11):1282-8. doi: 10.1038/ki.2008.108. Epub 2008 Apr 2. Kidney Int. 2008. PMID: 18385667
Renal improvement in myeloma with bortezomib plus plasma exchange.
Burnette BL, Leung N, Rajkumar SV. Burnette BL, et al. N Engl J Med. 2011 Jun 16;364(24):2365-6. doi: 10.1056/NEJMc1101834. N Engl J Med. 2011. PMID: 21675906 No abstract available.